Hold on to Isis Pharmaceuticals (ISIS)
Today's Financial News - Posted January 6, 2009
We’ve hit the anticipated double-digit gains on Isis Pharmaceuticals. But hold on! There’s more potential upside here…
by Laura Cadden, TodaysFinancialNews.com
Baltimore — (TFN): For my Editor’s PIC on December 17, I told TFN readers that the time had come to buy Isis Pharmaceuticals, Inc. (NASDAQ:ISIS): http://www.todaysfinancialnews.com/editors-pic/its-time-to-buy-isis-pharmaceuticals-isis-6636.html
I anticipated that the finalization of the sales of Isis’ Ibis Biosciences, Inc. division to Abbott Laboratories (NYSE:ABT) would bump up the stock price by double digits.
And here we are…
If you followed my advice and bought under under $13, you should be up 10%.
Now, if you’d like to play it safe and take the gains, I understand.
But the more I look at Isis and it’s “antisense” technology (for more details on this, see my original article), the more bullish I remain on this company. All indications are that this stock will continue to climb.
I recommend you hold onto shares of Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) for at least 20% gains.
Next Article: Beta strategy pays off: Triple-digit gains!
Be the first to leave a reply.
Your comments are welcome
Follow TFN via RSS or Twitter |
 |
 |
 |
Advertisement
Latest Headlines
- The Big Picture for Sinobiopharma, Inc. (SNBP)
- Beazer Homes USA, Inc. (BZH) and Hovnanian Enterprises, Inc. (HOV) up despite horrid housing news
- The FDA catalyst: 2010 moves in MannKind (MNKD), Roche Holding (RHHBY), Acorda Therapeutics (ACOR) show it still works!
- Steepest drop since Feb. 2009: Here we go again!
- Is the silver run over? Coeur d’Alene Mines (CDE), Silver Wheaton (SLW), Alto Group (ALTO), Hecla Mining (HL), Endeavour Silver (EXK) close down